Development of a novel weight bearing bone biomaterial of calcium polyphosphate (CPP) infiltrated with dicalcium phosphate containing a bone anabolic drug.

开发一种新型承重骨生物材料聚磷酸钙(CPP),其中渗透有含有骨合成代谢药物的磷酸二钙。

基本信息

  • 批准号:
    RGPIN-2018-03721
  • 负责人:
  • 金额:
    $ 2.4万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Discovery Grants Program - Individual
  • 财政年份:
    2020
  • 资助国家:
    加拿大
  • 起止时间:
    2020-01-01 至 2021-12-31
  • 项目状态:
    已结题

项目摘要

Goal: To develop a CPP construct infiltrated with monetite which incorporates in its matrix a bone anabolic conjugate drug and to maximize the mechanical properties of the construct and optimize its rate of degradation and increase the rate of bone ingrowth. Background: There is a strong need for biodegradable load-bearing bone substitutes for filling bone void defects, alveolar ridge augmentation, spinal cages used in association with spinal fusion procedures. Porous bulk calcium polyphosphate (CPP) constructs may satisfy this need as it is biocompatible, osteoconductive and strong. However, CPP constructs dissolve at a rate much slower in the bone environment than bone formation rate. Dicalcium phosphate biomaterials, such as monetite, have been shown to be biocompatible and osteoconductive. They have the ability to resorb in vivo faster enabling the replacement of the graft by new bone. Feasibility: During the tenure of the previous grant, we have reported a 2-step sinter/anneal treatment for forming porous CPP as a biodegradable bone substitute. To increase the degradation rate without loss of strength of the CPP, we started a study to investigate the effect of doping on mechanical properties and degradation rate. In addition, our collaborative group has developed a method to fabricate monetite constructs that incorporates in their cement matrix a novel bone anabolic conjugate of a bisphosphonate (alendronate) and an EP4 receptor agonist known as C3. One of these constructs of monetite has been implanted on rabbit calvarium and has integrated with the bone surface. The preliminary data is very promising and we believe that constructs of CPP infiltrated with monetite containing C3 can be optimized to improve degradation and function. Objectives: The specific objectives of this project would be: (i) Fabrication, modification and characterize CPP constructs; (ii) Modification of CPP constructs by infiltration with monetite loaded with C3 conjugate drug; (iii) Assess the conjugate binding and stability within the constructs; (iv) Assess degradation of the constructs; (v) Show in vivo efficacy of constructs via a bone implantation pilot study. Significance: Suitable biodegradable materials are important for bone applications and their success. Tailoring the properties of the CPP/monetite/C3 constructs would produce materials with desirable mechanical and chemical properties of a resorbable bone implant for load bearing bone replacement biomaterials.
目标:开发一种渗透有三斜磷钙石的CPP结构,其在其基质中掺入骨合成代谢缀合物药物,并使结构的机械性能最大化,优化其降解速率并增加骨长入速率。 背景资料:对于可生物降解的承重骨替代物存在强烈的需求,其用于填充骨空隙缺损、牙槽嵴增大、与脊柱融合手术相关联地使用的脊柱笼。多孔块状聚磷酸钙(CPP)结构可以满足这一需求,因为它具有生物相容性、骨传导性和强度。然而,CPP结构在骨环境中的溶解速率比骨形成速率慢得多。磷酸二钙生物材料,如三斜磷钙石,已被证明具有生物相容性和骨传导性。它们能够在体内更快地吸收,从而能够用新骨替代移植物。 可行性:在上一个资助的任期内,我们已经报告了一种2步烧结/退火处理,用于形成多孔CPP作为可生物降解的骨替代物。为了提高降解速率而不损失CPP的强度,我们开始研究掺杂对机械性能和降解速率的影响。此外,我们的合作小组已经开发出一种方法来制造三斜磷钙石结构,其在其水泥基质中掺入双膦酸盐(阿仑膦酸盐)和称为C3的EP 4受体激动剂的新型骨合成代谢缀合物。其中一种三斜磷钙石结构已植入兔颅骨,并与骨表面整合。初步的数据是非常有希望的,我们相信,CPP的构建体渗透含有C3的三斜磷钙石可以优化,以改善降解和功能。 目的:本项目的具体目标是:(i)制造、修饰和表征CPP结构;(ii)通过用负载C3结合药物的三斜磷钙石渗透修饰CPP结构;(iii)评估结构内的结合物结合和稳定性;(iv)评估结构的降解;(v)通过骨植入初步研究显示结构的体内功效。 意义:合适的生物可降解材料对于骨应用及其成功至关重要。定制CPP/三斜磷钙石/C3结构的性质将产生具有可再吸收骨植入物的理想机械和化学性质的材料,用于承重骨置换生物材料。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Grynpas, Marc其他文献

A review of phosphate mineral nucleation in biology and geobiology.
  • DOI:
    10.1007/s00223-013-9784-9
  • 发表时间:
    2013-10
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Omelon, Sidney;Ariganello, Marianne;Bonucci, Ermanno;Grynpas, Marc;Nanci, Antonio
  • 通讯作者:
    Nanci, Antonio
Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.
  • DOI:
    10.1002/jbmr.374
  • 发表时间:
    2011-08
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Bushinsky, David A.;Willett, Thomas;Asplin, John R.;Culbertson, Christopher;Che, Sara P. Y.;Grynpas, Marc
  • 通讯作者:
    Grynpas, Marc
Ontogenetic changes to bone microstructure in an archaeologically derived sample of human ribs
  • DOI:
    10.1111/joa.13116
  • 发表时间:
    2019-11-15
  • 期刊:
  • 影响因子:
    2.4
  • 作者:
    Beresheim, Amy C.;Pfeiffer, Susan;Grynpas, Marc
  • 通讯作者:
    Grynpas, Marc
Genetic Hypercalciuric Stone-Forming Rats Have a Primary Decrease in BMD and Strength
  • DOI:
    10.1359/jbmr.090223
  • 发表时间:
    2009-08-01
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Grynpas, Marc;Waldman, Stephen;Bushinsky, David A.
  • 通讯作者:
    Bushinsky, David A.
In vitro non-enzymatic ribation reduces post-yield strain accommodation in cortical bone
  • DOI:
    10.1016/j.bone.2012.11.014
  • 发表时间:
    2013-02-01
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Willett, Thomas L.;Sutty, Sibi;Grynpas, Marc
  • 通讯作者:
    Grynpas, Marc

Grynpas, Marc的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Grynpas, Marc', 18)}}的其他基金

Development of a novel weight bearing bone biomaterial of calcium polyphosphate (CPP) infiltrated with dicalcium phosphate containing a bone anabolic drug.
开发一种新型承重骨生物材料聚磷酸钙(CPP),其中渗透有含有骨合成代谢药物的磷酸二钙。
  • 批准号:
    RGPIN-2018-03721
  • 财政年份:
    2022
  • 资助金额:
    $ 2.4万
  • 项目类别:
    Discovery Grants Program - Individual
Development of a novel weight bearing bone biomaterial of calcium polyphosphate (CPP) infiltrated with dicalcium phosphate containing a bone anabolic drug.
开发一种新型承重骨生物材料聚磷酸钙(CPP),其中渗透有含有骨合成代谢药物的磷酸二钙。
  • 批准号:
    RGPIN-2018-03721
  • 财政年份:
    2021
  • 资助金额:
    $ 2.4万
  • 项目类别:
    Discovery Grants Program - Individual
Development of a novel weight bearing bone biomaterial of calcium polyphosphate (CPP) infiltrated with dicalcium phosphate containing a bone anabolic drug.
开发一种新型承重骨生物材料聚磷酸钙(CPP),其中渗透有含有骨合成代谢药物的磷酸二钙。
  • 批准号:
    RGPIN-2018-03721
  • 财政年份:
    2019
  • 资助金额:
    $ 2.4万
  • 项目类别:
    Discovery Grants Program - Individual
Development of a novel weight bearing bone biomaterial of calcium polyphosphate (CPP) infiltrated with dicalcium phosphate containing a bone anabolic drug.
开发一种新型承重骨生物材料聚磷酸钙(CPP),其中渗透有含有骨合成代谢药物的磷酸二钙。
  • 批准号:
    RGPIN-2018-03721
  • 财政年份:
    2018
  • 资助金额:
    $ 2.4万
  • 项目类别:
    Discovery Grants Program - Individual
A strategy to optimize the strength and degradation rate of calcium polyphosphates biomaterials
优化聚磷酸钙生物材料强度和降解率的策略
  • 批准号:
    250629-2012
  • 财政年份:
    2016
  • 资助金额:
    $ 2.4万
  • 项目类别:
    Discovery Grants Program - Individual
A strategy to optimize the strength and degradation rate of calcium polyphosphates biomaterials
优化聚磷酸钙生物材料强度和降解率的策略
  • 批准号:
    250629-2012
  • 财政年份:
    2015
  • 资助金额:
    $ 2.4万
  • 项目类别:
    Discovery Grants Program - Individual
Irradiation-sterilized skeletal allografts with superior biomechanical performance through collaborative multidisciplinary Translational Research
通过多学科合作转化研究,辐射灭菌的同种异体骨骼具有卓越的生物力学性能
  • 批准号:
    446523-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 2.4万
  • 项目类别:
    Collaborative Health Research Projects
A strategy to optimize the strength and degradation rate of calcium polyphosphates biomaterials
优化聚磷酸钙生物材料强度和降解率的策略
  • 批准号:
    250629-2012
  • 财政年份:
    2014
  • 资助金额:
    $ 2.4万
  • 项目类别:
    Discovery Grants Program - Individual
A strategy to optimize the strength and degradation rate of calcium polyphosphates biomaterials
优化聚磷酸钙生物材料强度和降解率的策略
  • 批准号:
    429446-2012
  • 财政年份:
    2014
  • 资助金额:
    $ 2.4万
  • 项目类别:
    Discovery Grants Program - Accelerator Supplements
Irradiation-sterilized skeletal allografts with superior biomechanical performance through collaborative multidisciplinary Translational Research
通过多学科合作转化研究,辐射灭菌的同种异体骨骼具有卓越的生物力学性能
  • 批准号:
    446523-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 2.4万
  • 项目类别:
    Collaborative Health Research Projects

相似国自然基金

Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
  • 批准号:
    82070530
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
  • 批准号:
    32002421
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
  • 批准号:
    31902347
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Comprehensive Examination of Novel Risk Factors for Development of Lifestyle-related Diseases by Metallomics Analysis by Molecular Weight
通过分子量金属组学分析全面检查生活方式相关疾病发生的新危险因素
  • 批准号:
    23K17444
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Study of the Development and Function of the Uterine Lymphatics
子宫淋巴管发育和功能的研究
  • 批准号:
    10752545
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
Development of a Piezoelectric Intramedullary Nail for Enhanced Fracture Healing
开发用于增强骨折愈合的压电髓内钉
  • 批准号:
    10759862
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
Development of peptide drug conjugates for cancer therapy
开发用于癌症治疗的肽药物缀合物
  • 批准号:
    10760236
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
Development of edible sorbent therapies to mitigate dietary exposures to per- and polyfluoroalkyl substances (PFAS)
开发可食用吸附剂疗法以减少膳食中全氟烷基物质和多氟烷基物质 (PFAS) 的暴露
  • 批准号:
    10590799
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
A pilot feasibility study of digitally delivered modules focused on preventing the development of obesity during the first year of life within an existing statewide home visitation program
对数字交付模块进行试点可行性研究,重点是在现有的全州家访计划中预防生命第一年发生肥胖
  • 批准号:
    10667696
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines
基于轮状病毒的产肠毒素大肠杆菌双重疫苗的研制
  • 批准号:
    10741541
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
Development of a clinically relevant mouse model of lung cancer cachexia to study pathoetiology and therapeutic strategies
开发临床相关的肺癌恶病质小鼠模型以研究病理学和治疗策略
  • 批准号:
    10729653
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
Development of a tele-mentoring system integrated into an ultra-portable surgical microscope to treat cataract in underserved populations
开发集成到超便携式手术显微镜中的远程指导系统,以治疗服务不足人群的白内障
  • 批准号:
    10602749
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
Development of neutral sphingomyelinase 2 (nSMase2) inhibitors for the treatment of Alzheimer's disease
开发用于治疗阿尔茨海默病的中性鞘磷脂酶 2 (nSMase2) 抑制剂
  • 批准号:
    10777029
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了